{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:52:27Z","timestamp":1790218347995,"version":"4.1.0"},"reference-count":60,"publisher":"Informa UK Limited","issue":"sup3","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100001839","name":"\u00a0UGC\u00a0\u00a0","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Grants Commission."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Artificial Cells, Nanomedicine, and Biotechnology"],"published-print":{"date-parts":[[2018,11,12]]},"DOI":"10.1080\/21691401.2018.1513941","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T13:20:12Z","timestamp":1539264012000},"page":"818-831","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":49,"title":["Combined adjuvant-delivery system for new generation vaccine antigens: alliance has its own advantage"],"prefix":"10.1080","volume":"46","author":[{"given":"Monika","family":"Kaurav","sequence":"first","affiliation":[{"name":"SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya","place":["Bilaspur, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Madan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Chandigarh College of Pharmacy","place":["Mohali, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Sudheesh","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, VNS Group of Institutions, Nathu Barkheda","place":["Bhopal, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Shankar","family":"Pandey","sequence":"additional","affiliation":[{"name":"SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya","place":["Bilaspur, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1176"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720111795256192"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.14.187"},{"key":"e_1_3_3_5_1","first-page":"779","article-title":"Novel adjuvants & delivery vehicles for vaccines development: a road ahead","volume":"138","author":"Mohan T","year":"2013","unstructured":"Mohan T, Verma P, Rao DN. Novel adjuvants & delivery vehicles for vaccines development: a road ahead. Indian J Med Res. 2013;138:779\u2013795.","journal-title":"Indian J Med Res"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-009-0114-3"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.04.036"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.12.372"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2017.06.002"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(00)00120-5"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.01.015"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1121989"},{"key":"e_1_3_3_13_1","first-page":"15","article-title":"Non-invasive administration of biodegradable nano-carrier vaccines","volume":"9","author":"Kalam MA","year":"2017","unstructured":"Kalam MA, Khan AA, Alshamsan A. Non-invasive administration of biodegradable nano-carrier vaccines. Am J Trans Res. 2017;9:15\u201335.","journal-title":"Am J Trans Res"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23757"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(98)00040-4"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.3.401"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1306440"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.042"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws196"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-0344(01)00101-0"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2014.06.002"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2011.02.004"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712591003724662"},{"key":"e_1_3_3_24_1","unstructured":"U.S. Food and drug administration 2018 United States. (Accessed 2018 March 20).Available from: https:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm473989.htm (Flaud)."},{"key":"e_1_3_3_25_1","unstructured":"European medicines agency 2017 United Kingdom. (Accessed 2018 April 2).Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Product_Information\/human\/001208\/WC500049684.pdf (Foclivia)."},{"key":"e_1_3_3_26_1","unstructured":"European medicines agency 2017 United Kingdom. (Accessed 2018 April 2).Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Product_Information\/human\/002094\/WC500101080.pdf(Aflunov)."},{"key":"e_1_3_3_27_1","unstructured":"European medicines agency 2017 United Kingdom. (accessed 2018 April 2).Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Public_statement\/2016\/02\/WC500201798.pdf(Foectoria)."},{"key":"e_1_3_3_28_1","unstructured":"European medicines agency 2017 United Kingdom. (Accessed 2018 April 2).Available from: http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/Pandemrix_Package_Insert.pdf (Pandemrix)."},{"key":"e_1_3_3_29_1","unstructured":"European medicines agency 2017 United Kingdom. (Accessed 2018 April 2).Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Product_Information\/human\/000822\/WC500041466.pdf\/http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR-Summary_for_the_public\/human\/000822\/WC500041467.pdf (Prepandrix)."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.07.021"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.1.1.111"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.08.049"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.08.004"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636959"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2014_1875"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00345"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1028-4559(08)60004-2"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.05.036"},{"key":"e_1_3_3_39_1","unstructured":"U.S. Food and drug administration 2018 United States. (Accessed 2018 March 21).Available from: https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM110114.pdf (Recombivax)."},{"key":"e_1_3_3_40_1","unstructured":"Strategic advisory group of expertson immunization by the hepatitis E vaccine working group from World Health Organization 2014. Geneva Switzerland. (Retrieved 2014 October 1).Available from: http:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/2_HepEvaccsafety_immunogenicity_efficacy_final_1Oct2014.pdf (Hepatitis E)."},{"key":"e_1_3_3_41_1","unstructured":"U.S. Food and drug administration 2018 United States. (Accessed 2018 April 21). Available from: https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm186981.pdf (Cervarix)."},{"key":"e_1_3_3_42_1","unstructured":"U.S. Food and drug administration 2018 United States. (Accessed 2018 April 21). Available from: https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM111263.pdf (Gardasil)."},{"key":"e_1_3_3_43_1","unstructured":"U.S. Food and drug administration 2018 United States. (Accessed 2018 April 21).Available from: https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm426457.pdf (Gardasil 9)."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00431"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(99)00017-X"},{"key":"e_1_3_3_46_1","unstructured":"Janssen Pharmaceutical Companies 2018. (Accessed 2018 March31).Available from: http:\/\/www.janssen.com\/infectious-diseases-and-vaccines\/crucell."},{"key":"e_1_3_3_47_1","unstructured":"Electronic Medicines Compendium of UK medicines and healthcare products egulatory agency and the European medicines agency 2018. Accessed 2018 April12).Available from: https:\/\/www.medicines.org.uk\/emc\/product\/4035\/smpc."},{"key":"e_1_3_3_48_1","unstructured":"European medicines agency 2015. (Accessed 2018 April 8).Available from: https:\/\/mri.cts-mrp.eu\/Human\/Downloads\/IT_H_0107_001_FinalPL.pdf."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.4.5742"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00155"},{"key":"e_1_3_3_51_1","unstructured":"U.S. Food and drug administration 2018 United States. (Accessed 2018 April 25).Available from: https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM581605.pdf (SHINGRIX)."},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12143"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/308457a0"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/095646249500600611"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.05.013"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b00434"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2629"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030595"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2731"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009862"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.5.2990"}],"container-title":["Artificial Cells, Nanomedicine, and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21691401.2018.1513941","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21691401.2018.1513941","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21691401.2018.1513941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:10:52Z","timestamp":1785172252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21691401.2018.1513941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":60,"journal-issue":{"issue":"sup3","published-print":{"date-parts":[[2018,11,12]]}},"alternative-id":["10.1080\/21691401.2018.1513941"],"URL":"https:\/\/doi.org\/10.1080\/21691401.2018.1513941","relation":{},"ISSN":["2169-1401","2169-141X"],"issn-type":[{"value":"2169-1401","type":"print"},{"value":"2169-141X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ianb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ianb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}